Simultaneous determination of plasma creatinine, uric acid, kynurenine and tryptophan by high-performance liquid chromatography: Method validation and in application to the assessment of renal function

Biomedical Chromatography

Volumn 29, Issue 3, 2015, Pages 410-415

  Zhao, Jianxing ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Creatinine; High performance liquid chromatography; Kynurenine; Plasma; Tryptophan; Uric acid

Indexed keywords

AMINO ACIDS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

AGILENT; ANALYTES; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; KYNURENINE; METHOD VALIDATIONS; RENAL FUNCTIONS; SIMULTANEOUS DETERMINATIONS; TRYPTOPHAN; ULTRAVIOLET DETECTION METHODS; URIC ACIDS;

CREATININE;

CREATININE; KYNURENINE; TRYPTOPHAN; URIC ACID;

ANALYTIC METHOD; ARTICLE; CREATININE BLOOD LEVEL; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FUNCTION; LIMIT OF DETECTION; URIC ACID BLOOD LEVEL; VALIDATION PROCESS; ADULT; AGED; BLOOD; FEMALE; HYPERTENSION; KIDNEY FUNCTION TEST; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC; VALIDATION STUDY;

ADULT; AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATININE; FEMALE; HUMANS; HYPERTENSION; KIDNEY FUNCTION TESTS; KYNURENINE; LIMIT OF DETECTION; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; TRYPTOPHAN; URIC ACID;

EID: 84920990422     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.3291     Document Type: Article

References (32)

1. Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS and McClellan W. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney International 2003; 64: 610-615.
2. Bellomo G, Venanzi S, Verdura C, Saronio P, Esposito A and Timio M. Association of uric acid with change in kidney function in healthy normotensive individuals. American Journal of Kidney Diseases 2010; 56: 264-272.
3. de Bruin JL, Vervloet MG, Buimer MG, Baas AF, Prinssen M, Blankensteijn JD and Group DS. Renal function 5years after open and endovascular aortic aneurysm repair from a randomized trial. The British Journal of Surgery 2013; 100: 1465-1470.
4. Herve C, Beyne P, Jamault H and Delacoux E. Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection. Journal of Chromatography B 1996; 675: 157-161.
5. Holmes EW. Determination of serum kynurenine and hepatic tryptophan dioxygenase activity by high-performance liquid chromatography. Analytical Biochemistry 1988; 172: 518-525.
6. Iizuka H, Hirasa Y, Kubo K, Ishii K, Toyo'oka T and Fukushima T. Enantiomeric separation of d, l-tryptophan and d, l-kynurenine by HPLC using pre-column fluorescence derivatization with R(-)-DBD-PyNCS. Biomedical Chromatography 2011; 25: 743-747.
7. Koteff J, Borland J, Chen S, Song I, Peppercorn A, Koshiba T, Cannon C, Muster H and Piscitelli SC. A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para-aminohippurate clearance in healthy subjects. British Journal of Clinical Pharmacology 2013; 75: 990-996.
8. Koyama FC, Carvalho TL, Alves E, da Silva HB, de Azevedo, MF, Hemerly AS and Garcia CR. The structurally related auxin and melatonin tryptophan-derivatives and their roles in Arabidopsis thaliana and in the human malaria parasite Plasmodium falciparum. The Journal of Eukaryotic Microbiology 2013; 60: 646-651.
9. Kurella Tamura M, Wadley V, Yaffe K, McClure LA, Howard G, Go R, Allman RM, Warnock DG and McClellan W. Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. American Journal of Kidney Diseases 2008; 52: 227-234.
10. Kutzing MK and Firestein BL. Altered uric acid levels and disease states. The Journal of Pharmacology and Experimental Therapeutics 2008; 324: 1-7.
11. Laich A, Neurauter G, Widner B and Fuchs D. More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clinical Chemistry 2002; 48: 579-581.
12. Nakayama M, Metoki H, Terawaki H, Ohkubo T, Kikuya M, Sato T, Nakayama K, Asayama K, Inoue R, Hashimoto J et al. Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population - the Ohasama study. Nephrology, Dialysis, Transplantation 2007; 22: 1910-1915.
13. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American Journal of Kidney Diseases 2002; 39: S1-266.
14. Nguyen DT, Cho IS, Kim JW, Kim KR, Lee G and Paik MJ. Acidic metabolite profiling analysis of catecholamine and serotonin as O-ethoxycarbonyl/tert-butyldimethylsilyl derivatives by gas chromatography-mass spectrometry. Biomedical Chromatography 2013; 27: 216-221.
15. Pawlak K, Brzosko S, Mysliwiec M and Pawlak D. Kynurenine, quinolinic acid - the new factors linked to carotid atherosclerosis in patients with end-stage renal disease. Atherosclerosis 2009; 204: 561-566.
16. Pilli NR, Mullangi R, Inamadugu JK, Nallapati IK and Rao JV. Simultaneous determination of simvastatin, lovastatin and niacin in human plasma by LC-MS/MS and its application to a human pharmacokinetic study. Biomedical Chromatography 2012; 26: 476-484.
17. Ravi VB, Mullangi R, Inamadugu JK, Pilli NR, Gajula R and Ponneri V. Simultaneous determination of atorvastatin and niacin in human plasma by LC-MS/MS and its application to a human pharmacokinetic study. Biomedical Chromatography 2012; 26: 1436-1443.
18. Saito K, Fujigaki S, Heyes MP, Shibata K, Takemura M, Fujii H, Wada H, Noma A and Seishima M. Mechanism of increases in l-kynurenine and quinolinic acid in renal insufficiency. American Journal of Physiology. Renal Physiology 2000; 279: F565-572.
19. Schefold JC, Zeden JP, Fotopoulou C, von Haehling S, Pschowski R, Hasper D, Volk HD, Schuett C and Reinke P. Increased indoleamine 2, 3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms. Nephrology, Dialysis, Transplantation 2009; 24: 1901-1908.
20. Seki T, Yamaji K, Orita Y, Moriguchi S and Shinoda A. Simultaneous determination of uric acid and creatinine in biological fluids by column-switching liquid chromatography with ultraviolet detection. Journal of Chromatography A 1996; 730: 139-145.
21. Silverberg D, Wexler D, Blum M, Schwartz D and Iaina A. The association between congestive heart failure and chronic renal disease. Current Opinion in Nephrology and Hypertension 2004; 13: 163-170.
22. US Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry, Bioanalytical Method Evaluation. US Department of Health and Human Services, Food and Drug Administration: Rockville, MD, 2001.
23. Vignau J, Jacquemont MC, Lefort A, Imbenotte M and Lhermitte M. Simultaneous determination of tryptophan and kynurenine in serum by HPLC with UV and fluorescence detection. Biomedical Chromatography 2004; 18: 872-874.
24. Yang YD. Simultaneous determination of creatine, uric acid, creatinine and hippuric acid in urine by high performance liquid chromatography. Biomedical Chromatography 1998; 12: 47-49.
25. Yubero-Lahoz S, Rodriguez J, Faura A, Pascual J, Oliveras A, Cao H, Farre M and de la Torre R. Determination of free serotonin and its metabolite 5-HIAA in blood human samples with consideration to pre-analytical factors. Biomedical Chromatography 2014; doi:10.1002/bmc.3192.
26. Zhang X, He Y and Ding M. Simultaneous determination of tryptophan and kynurenine in plasma samples of children patients with Kawasaki disease by high-performance liquid chromatography with programmed wavelength ultraviolet detection. Journal of Chromatography B 2009; 877: 1678-1682.
27. Zhao J. Plasma kynurenic acid/tryptophan ratio: a sensitive and reliable biomarker for the assessment of renal function. Renal Failure 2013a; 35: 648-653.
28. Zhao J. A simple, rapid and reliable high performance liquid chromatography method for the simultaneous determination of creatinine and uric acid in plasma and urine. Analytical Methods 2013b; 5: 6781-6787.
29. Zhao YY. Metabolomics in chronic kidney disease. Clinica Chimica Acta 2013c; 422: 59-69.
30. 2+-containing mobile phase for simultaneous determination of kynurenine, kynurenic acid and tryptophan in human plasma by high performance liquid chromatography. Journal of Chromatography B 2010; 878: 603-608.
31. Zhao J, Chen H, Ni P, Xu B, Luo X, Zhan Y, Gao P and Zhu D. Simultaneous determination of urinary tryptophan, tryptophan-related metabolites and creatinine by high performance liquid chromatography with ultraviolet and fluorimetric detection. Journal of Chromatography B 2011; 879: 2720-2725.
32. Zhiri A, Houot O, Wellman-Bednawska M and Siest G. Simultaneous determination of uric acid and creatinine in plasma by reversed-phase liquid chromatography. Clinical Chemistry 1985; 31: 109-112.